Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acupuncture in Chemotherapy-induced Peripheral Neuropathy
NCT05673746Unknown
- Sponsor
- Sant'Orsola-Malpighi University Hospital
- Start
- Sep 2020
- Primary completion
- Dec 2023
- Countries
- 1
01
Overview
Randomised, open-label trial in chemotherapy-induced peripheral neuropathy (CIPN) and neuropathic pain (2 arms), sponsored by Sant'Orsola-Malpighi University Hospital. Primary endpoint: Numeric Rating Scale for neuropathic pain at 6 weeks. Status: unknown.
02
Conditions
chemotherapy-induced peripheral neuropathy (CIPN)neuropathic pain
Beyond the preview
Go deeper on NCT05673746.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05673746.